Global Intrathecal Drug Market Insights, Forecast

Intrathecal administration is a route of administration for drugs via an injection into the spinal canal, or into the subarachnoid space so that it reaches the cerebrospinal fluid (CSF) and is useful in spinal anaesthesia, chemotherapy, or pain management applications. This route is also used to introduce drugs that fight certain infections, particularly post-neurosurgical. The drug needs to be given this way to avoid being stopped by the blood brain barrier. The same drug given orally must enter the blood stream and may not be able to pass out and into the brain. Drugs given by the intrathecal route often have to be compounded specially by a pharmacist or technician because they cannot contain any preservative or other potentially harmful inactive ingredients that are sometimes found in standard injectable drug preparations. The global Intrathecal Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Intrathecal Drug market based on company, product type, end user and key regions. This report studies the global market size of Intrathecal Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intrathecal Drug in these regions. This research report categorizes the global Intrathecal Drug market by top players/brands, region, type and end user. This report also studies the global Intrathecal Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company: Medtronic Jazz Pharmaceuticals West Ward Pharmaceutical Saol Therapeutics Piramal Critical Care Fresenius Kabi Market size by Product Baclofen injection Ziconotide Intrathecal Infusion Morphine injection Market size by End User Adult Child & Teen Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Intrathecal Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. To understand the structure of Intrathecal Drug market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Intrathecal Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of Intrathecal Drug submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of Intrathecal Drug are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Intrathecal Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Get sample copy of the report:

https://www.marketdensity.com/contact?ref=Sample&reportid=122135

Table of Contents:

Table of Contents

1 Study Coverage
1.1 Intrathecal Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Intrathecal Drug Market Size Growth Rate by Product
1.4.2 Baclofen injection
1.4.3 Ziconotide Intrathecal Infusion
1.4.4 Morphine injection
1.5 Market by End User
1.5.1 Global Intrathecal Drug Market Size Growth Rate by End User
1.5.2 Adult
1.5.3 Child & Teen
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Intrathecal Drug Market Size
2.1.1 Global Intrathecal Drug Revenue 2014-2025
2.1.2 Global Intrathecal Drug Sales 2014-2025
2.2 Intrathecal Drug Growth Rate by Regions
2.2.1 Global Intrathecal Drug Sales by Regions
2.2.2 Global Intrathecal Drug Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Intrathecal Drug Sales by Manufacturers
3.1.1 Intrathecal Drug Sales by Manufacturers
3.1.2 Intrathecal Drug Sales Market Share by Manufacturers
3.1.3 Global Intrathecal Drug Market Concentration Ratio (CR5 and HHI)
3.2 Intrathecal Drug Revenue by Manufacturers
3.2.1 Intrathecal Drug Revenue by Manufacturers (2014-2019)
3.2.2 Intrathecal Drug Revenue Share by Manufacturers (2014-2019)
3.3 Intrathecal Drug Price by Manufacturers
3.4 Intrathecal Drug Manufacturing Base Distribution, Product Types
3.4.1 Intrathecal Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Intrathecal Drug Product Type
3.4.3 Date of International Manufacturers Enter into Intrathecal Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Intrathecal Drug Sales by Product
4.2 Global Intrathecal Drug Revenue by Product
4.3 Intrathecal Drug Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Intrathecal Drug Breakdown Data by End User

6 North America
6.1 North America Intrathecal Drug by Countries
6.1.1 North America Intrathecal Drug Sales by Countries
6.1.2 North America Intrathecal Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Intrathecal Drug by Product
6.3 North America Intrathecal Drug by End User

7 Europe
7.1 Europe Intrathecal Drug by Countries
7.1.1 Europe Intrathecal Drug Sales by Countries
7.1.2 Europe Intrathecal Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Intrathecal Drug by Product
7.3 Europe Intrathecal Drug by End User

8 Asia Pacific
8.1 Asia Pacific Intrathecal Drug by Countries
8.1.1 Asia Pacific Intrathecal Drug Sales by Countries
8.1.2 Asia Pacific Intrathecal Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Intrathecal Drug by Product
8.3 Asia Pacific Intrathecal Drug by End User

9 Central & South America
9.1 Central & South America Intrathecal Drug by Countries
9.1.1 Central & South America Intrathecal Drug Sales by Countries
9.1.2 Central & South America Intrathecal Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Intrathecal Drug by Product
9.3 Central & South America Intrathecal Drug by End User

10 Middle East and Africa
10.1 Middle East and Africa Intrathecal Drug by Countries
10.1.1 Middle East and Africa Intrathecal Drug Sales by Countries
10.1.2 Middle East and Africa Intrathecal Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Intrathecal Drug by Product
10.3 Middle East and Africa Intrathecal Drug by End User

11 Company Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Company Business Overview
11.1.3 Medtronic Intrathecal Drug Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Medtronic Intrathecal Drug Products Offered
11.1.5 Medtronic Recent Development
11.2 Jazz Pharmaceuticals
11.2.1 Jazz Pharmaceuticals Company Details
11.2.2 Company Business Overview
11.2.3 Jazz Pharmaceuticals Intrathecal Drug Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Jazz Pharmaceuticals Intrathecal Drug Products Offered
11.2.5 Jazz Pharmaceuticals Recent Development
11.3 West Ward Pharmaceutical
11.3.1 West Ward Pharmaceutical Company Details
11.3.2 Company Business Overview
11.3.West Ward Pharmaceutical Intrathecal Drug Sales, Revenue and Gross Margin (2014-2019)
11.3.4 West Ward Pharmaceutical Intrathecal Drug Products Offered
11.3.5 West Ward Pharmaceutical Recent Development
11.4 Saol Therapeutics
11.4.1 Saol Therapeutics Company Details
11.4.2 Company Business Overview
11.4.3 Saol Therapeutics Intrathecal Drug Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Saol Therapeutics Intrathecal Drug Products Offered
11.4.5 Saol Therapeutics Recent Development
11.5 Piramal Critical Care
11.5.1 Piramal Critical Care Company Details
11.5.2 Company Business Overview
11.5.3 Piramal Critical Care Intrathecal Drug Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Piramal Critical Care Intrathecal Drug Products Offered
11.5.5 Piramal Critical Care Recent Development
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Details
11.6.2 Company Business Overview
11.6.3 Fresenius Kabi Intrathecal Drug Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Fresenius Kabi Intrathecal Drug Products Offered
11.6.5 Fresenius Kabi Recent Development

12 Future Forecast
12.1 Intrathecal Drug Market Forecast by Regions
12.1.1 Global Intrathecal Drug Sales Forecast by Regions 2019-2025
12.1.2 Global Intrathecal Drug Revenue Forecast by Regions 2019-2025
12.2 Intrathecal Drug Market Forecast by Product
12.2.1 Global Intrathecal Drug Sales Forecast by Product 2019-2025
12.2.2 Global Intrathecal Drug Revenue Forecast by Product 2019-2025
12.3 Intrathecal Drug Market Forecast by End User
12.4 North America Intrathecal Drug Forecast
12.5 Europe Intrathecal Drug Forecast
12.6 Asia Pacific Intrathecal Drug Forecast
12.7 Central & South America Intrathecal Drug Forecast
12.8 Middle East and Africa Intrathecal Drug Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Intrathecal Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Browse this report online:

https://www.marketdensity.com/global-intrathecal-drug-market-insights-forecast

About Market Density:

Market Density is your one stop market research and industry analysis reports' library providing business data and intelligence information on thousands of micro markets with global as well as regional coverage.
Market Density offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Market Density understands how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:

Email: sales@marketdensity.com

Website: www.marketdensity.com

Phone: +1 669 264 1656

4340 Stevens Creek Blvd,
Suite # 172,
San Jose, CA 95129

This release was published on openPR.